What is the TXG stock price prediction for next 2 weeks?

According to our price prediction algorithm,10x Genomics, Inc. (TXG) price will be around $20.56 in the next 2 weeks. This means it will decrease by -4.836574074074084 from the last closing price. This prediction may vary from other time period filters for TXG stock.

What can be the highest Possible price of TXG stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, TXG can achieve the highest price of $21.80 which is 0.9214681243722196 higher than last closing price. This prediction may vary from other time period filters for TXG stock.

What can be the lowest Possible price of TXG stock in next 2 weeks?

As per the forecast and algorithmic analysis, TXG stock price can be as low as $19.42 which is -10.115609343209739 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for TXG stock.

Will TXG stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that TXG stock will lose-4.836574074074084 in the next 2 weeks. This prediction may vary from other time period filters for TXG stock.

What is TXG stock last closing price?

Last closing price of TXG stock was $21.60.

What is TXG stock price prediction?

TXG stock price prediction means predicting the future closing prices of TXG stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of TXG stock in a certain time period.

How we predict TXG stock future prices?

If you are searching for TXG stock forecast, analysis or price prediction, then you might be wondering what 10x Genomics, Inc. (TXG) will do in the future. Our TXG price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This TXG price prediction will likely answer most of your questions.

How frequent we update TXG stock predictions?

We are updating the forecasts for the TXG stock on daily basis.

Is using ML forecasting for TXG stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for TXG stock same for all the time periods?

No, the prediction for TXG stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

10x Genomics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$21.600.84%Since 2 Weeks

Predicted Price$20.56-4.84%For 2 Weeks

Upper Predicted Price$21.800.92%For 2 Weeks

Lower Predicted Price$19.42-10.12%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of TXG will decline by -4.84% over the next 2 Weeks and hit $20.56 by Friday, May 22, 2026. In that time frame, TXG's share price is expected to range between $19.42 and $21.80.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 22, 2026	19.42	20.56	21.80
May 21, 2026	19.34	20.51	21.67
May 20, 2026	19.31	20.47	21.65
May 19, 2026	19.45	20.51	21.69
May 18, 2026	19.29	20.41	21.57
May 15, 2026	20.12	21.29	22.40
May 14, 2026	20.08	21.25	22.39
May 13, 2026	20.04	21.20	22.20
May 12, 2026	20.18	21.25	22.34
May 11, 2026	19.93	21.14	22.20

TXG shares fell -3.66% in Friday, May 8, 2026's trading session, dropping from a previous close of $22.42 to move at $21.60. The stock demonstrated notable intraday movement (see TXG's key stats for a full breakdown), fluctuating between $19.82 and $21.99, a +10.95% trading range. While recent weeks have seen some volatility, TXG has managed to secure a +0.84% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 4.83M shares changing hands, 2.6M more than the previous session. This amounted to $104.33M in total market activity.

Will TXG Continue Its Upward Trend?

According to analyst ratings and projections for TXG, 10x Genomics, Inc. shares are anticipated to increase by +0.91%, potentially reaching $21.80 per share by May 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for TXG. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the TXG stock forecast, now is a good time to buy TXG stock because its current trading price is +5.08% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TXG covering social and institutional perspectives.

TXG Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into TXG's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.70% to 49.07%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.10%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.77%, maintains a neutral outlook for the long term. Insights into TXG's shareholder base show how institutional investors are positioning themselves during these momentum shifts

10x Genomics Short-Term Forecasts

TXG Forecast For Next 5 Days

Our algorithm anticipates 10x Genomics (TXG) stock could hit $18.78 by May 15, 2026. This represents a -13.05% rise from today's price, following a +11.36% change over the past five days.

TXG Forecast For Next 30 Days

Based on analysis of market trends, the outlook for 10x Genomics, Inc. (TXG) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $20.83, which would mean a -3.56% decrease from the current price of $21.60. Projections for this period range from a high of $24.86 to a low of $17.04.

TXG Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for 10x Genomics's price over the next three months point to a drop. TXG stock is expected to peak at $25.97 on Jun 05, 2026 before potentially dipping to $13.51 on Aug 04, 2026. On average, TXG is likely to trade around $19.72 in the coming 90 days.

10x Genomics Stock Forecast 2025

Based on our predictive models, 10x Genomics (TXG) is expected to trade between $6.41 and $25.97 throughout 2026. This would result in an average price of $16.97, potentially offering investors a -21.44% return from current levels.

10x Genomics, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, 10x Genomics, Inc. (TXG) is positioned to show a strong performance in May 2026. The price is predicted to move between $16.80 and $24.98, settling at an average of $20.88. This could translate to a -3.33% loss.

June 2026

Based on current market signals, 10x Genomics, Inc. is projected to trend june 2026. We forecast a trading range from $15.34 to $25.97, with a likely average price of $20.94. Investors could expect a potential return of -3.06%.

July 2026

Our predictive algorithms indicate 10x Genomics, Inc. stock may see a shift in July 2026. The expected range spans $13.97–$22.54, with an average target of $18.31. This represents a cautious outlook and a possible loss of -15.23%.

August 2026

Analyzing established trends, 10x Genomics, Inc. looks set to move in August 2026. Projections place the stock between $13.51 and $21.82, averaging around $17.43. This suggests a -19.31% loss from current levels.

September 2026

Market indicators suggest 10x Genomics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $13.74 to $22.17, with a midpoint forecast of $17.83. The stock might deliver a -17.45% loss.

October 2026

Forecasting for October 2026, models estimate that 10x Genomics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $6.41 and $20.40, averaging $15.00. This signals a cautious trajectory with potential returns around -30.56%.

November 2026

According to our latest forecast models, 10x Genomics, Inc. (TXG) is positioned to show a strong performance in November 2026. The price is predicted to move between $8.52 and $19.36, settling at an average of $14.44. This could translate to a -33.15% loss.

December 2026

Based on current market signals, 10x Genomics, Inc. is projected to trend december 2026. We forecast a trading range from $7.62 to $17.22, with a likely average price of $12.20. Investors could expect a potential return of -43.52%.

January 2027

Our predictive algorithms indicate 10x Genomics, Inc. stock may see a shift in January 2027. The expected range spans $7.27–$15.90, with an average target of $11.32. This represents a cautious outlook and a possible loss of -47.59%.

February 2027

Analyzing established trends, 10x Genomics, Inc. looks set to move in February 2027. Projections place the stock between $7.23 and $16.13, averaging around $11.82. This suggests a -45.28% loss from current levels.

March 2027

Market indicators suggest 10x Genomics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $4.40 to $14.24, with a midpoint forecast of $9.14. The stock might deliver a -57.69% loss.

April 2027

Forecasting for April 2027, models estimate that 10x Genomics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.47 and $13.09, averaging $8.14. This signals a cautious trajectory with potential returns around -62.31%.

May 2027

According to our latest forecast models, 10x Genomics, Inc. (TXG) is positioned to show a strong performance in May 2027. The price is predicted to move between $2.13 and $9.78, settling at an average of $5.53. This could translate to a -74.40% loss.

TXG's history of dividends and stock splits also plays a role in long-term investor confidence.